共 50 条
- [21] Matching-Adjusted Indirect Comparison (MAIC) of Brexucabtagene Autoleucel (Brexu-cel) and Pirtobrutinib in Patients with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (cBTKi)BLOOD, 2023, 142Chen, Jenny M. H.Zhang, InaWu, James J.Wade, Sally W.Nunes, AnaPeng, WeiminSnider, Julia T.Maciel, DylanChan, KeithKeeping, SamShah, Bijal D.
- [22] Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton's Tyrosine Kinase Inhibitor in CanadaCURRENT ONCOLOGY, 2022, 29 (03) : 2021 - 2045Ball, GraemeLemieux, ChristopherCameron, DavidSeftel, Matthew D.
- [23] Cost Effectiveness of Mosunetuzumab and CAR-T Cell Therapy in Relapsed/Refractory Follicular LymphomaBLOOD, 2023, 142Lin, ManishaWeiss, JonathanPhillips, Tycel J.Sano, DahliaCarty, Shannon A.Ghosh, MonalisaAhmed, ImanNachar, VictoriaHutton, DavidKarimi, Yasmin H.
- [24] Brexucabtagene autoleucel for relapsed/refractory mantle cell lymphoma: Real-world experience from the United States lymphoma CAR T consortium.JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Jain, PreeteshWang, YucaiLocke, Frederick L.Munoz, JavierBeitinjaneh, AmerFrank, Matthew JoshuaDahiya, SaurabhJacobs, Miriam T.Hill, Brian T.Lekakis, Lazaros J.Miklos, David BernardGhobadi, ArminNeelapu, Sattva SwarupLin, YiWang, MichaelJain, Michael D.Maurer, Matthew J.
- [25] Primary Analysis of ZUMA-2 Cohort 3: Brexucabtagene Autoleucel (Brexu-Cel) in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Who Were Naive to Bruton Tyrosine Kinase Inhibitors (BTKi)BLOOD, 2024, 144 : 748 - 750van Meerten, TomKersten, M. J.Lacoboni, GloriaHess, GeorgMutsaers, PimGarcia-Sancho, Alejandro MartinGoy, AndreGine, EvaHill, Brian T.Weng, Wen-KaiDreyling, MartinReagan, Patrick M.Patel, KrishGalal, AhmedHerbaux, CharlesSanderson, RobinZheng, DanKanska, JustynaZhang, WangshuKhalid, Rita DamicoKloos, LoanaWang, Michael
- [26] COST-EFFECTIVENESS OF BREXUCABTAGENE AUTOLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN PATIENTS AGED 26 YEARS OR OLDER IN GREECEVALUE IN HEALTH, 2024, 27 (12) : S105 - S105Vellopoulou, K.Tsirigotis, P.Chondropoulos, S.Konstantellos, IQeodurasoy, N.Spousta, T.Van Hees, F.Smith, N.Doble, B.
- [27] A Comparison of Overall Survival with Brexucabtagene Autoleucel (Brexu-cel) CAR T-Cell Therapy (ZUMA-2) and Standard of Care (SCHOLAR-2) in Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor (BTKi)BLOOD, 2022, 140 : 10296 - 10299Hess, GeorgDreyling, MartinOberic, LucieGine, EvaZinzani, Pier LuigiLinton, Kim M.Vilmar, AdamJerkeman, MatsChen, Jenny M. H.Ohler, AnkeStilgenbauer, StephanThieblemont, CatherineLambert, JonathanZilioli, Vittorio RuggeroSancho, Juan-ManuelJimenez-Ubieto, AnaFischer, LucaEyre, Toby A.Keeping, SamPark, Julie E.Wu, James J.Siddiqi, RubinaReitan, JohnCastaigne, GabSalles, Gilles
- [28] Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registryHAEMATOLOGICA, 2024, 109 (11) : 3745 - 3750Herbaux, CharlesBret, CarolineBachy, EmmanuelBories, PierreDi Blasi, RobertaCuffel, AlexisGastinne, ThomasLamy, ThierryRoussel, MikaelBouabdallah, KrimoBeauvais, DavidCartron, GuillaumeBay, Jacques-OlivierBlaise, DidierRubio, Marie-ThereseMohty, MohamadLe Bras, FabienCasasnovas, OlivierGuy, JulienGuidez, StephanieLlorente, Cristina CastillaHermine, OlivierLa Rochelle, Laurianne DrieuCarras, SylvainGuffroy, BlandineCaillat-Zucman, SophieHouot, RochLe Gouill, Steven
- [29] Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real-World Outcomes in the United KingdomBLOOD, 2022, 140 : 7519 - 7521O'Reilly, Maeve A.Sanderson, RobinWilson, WilliamBurns, DavidBesley, CarolineCreasey, ThomasUttenthal, BenElliot, JohnathonRoddie, ClaireKuhnl, AndreaPaneesha, ShankaraSeymour, FrancesIyengar, SunilRubio, LourdesWilson, MatthewBoyle, StephenCheok, Kathleen PlCollins, Graham P.Johnson, RodMcMillan, Andrew K.
- [30] Bridging Radiotherapy prior to Brexucabtagene Autoleucel CAR T-Cell Therapy in Mantle Cell LymphomaRADIOTHERAPY AND ONCOLOGY, 2021, 161 : S894 - S895Figura, N.Sim, A.Dahiya, S.Lutfi, F.Rapoport, A.Mohindra, P.Dohm, A.Chavez, J.Shah, B.Khimani, F.Lazaryan, A.Davila, M.Bachmeier, C.Nishihori, T.Liu, H.Kim, S.Locke, F.Jain, M.Robinson, T.